North America Digital PCR and qPCR Market

North America Digital PCR and qPCR Market Size  (2024 to 2029)

The size of the North America Digital PCR and qPCR Market accounted for USD 1.34 billion in 2024. It is expected to grow at 9.02% and is predicted to be around USD 2.07 billion in 2029.

Rapid commercialization of PCR and qPCR products in North America boosts the growth of the digital PCR and qPCR market in North America.

Furthermore, the emergence of technologically advanced products is another major factor that fuels the growth rate of the North American digital PCR and qPCR market. In addition, the rising account of research and development activities in genomics and the availability of advanced research infrastructure facilities in the region are propelling the growth rate of the North America Digital PCR and qPCR Market. 

Increasing expenditure of healthcare and emerging economies of countries like Canada, the U.S, Brazil, and other countries in North America owing to technological advancements and the presence of key market players are offering lucrative opportunities for the market's growth and expected to continue the trend during the forecast period. Furthermore, the steadily increasing population affected with genetic disorders leading to a rise in demand for practical and faster diagnostic tests is foreseen to provide opportunities for the North American digital PCR and qPCR market during the forecast period. In addition, increasing adoption of PCR techniques in diagnostic centers and hospital research and commercial purposes is presumed to offer several opportunities for the North American digital PCR and qPCR market growth.

The primary factor limiting the growth of the North American digital PCR and the qPCR market is the expensive nature of digital PCR devices due to the high manufacturing costs. In addition, the shortage of skilled labor to handle the systems effectively is another major factor restraining the growth of the North American digital PCR and qPCR market. 

This research report on the North American digital PCR and qPCR market has been segmented & sub-segmented into the following categories

North America Digital PCR and qPCR Market Analysis By Product

• Consumables

• Reagents and Instruments

North America Digital PCR and qPCR Market Analysis By Technology

• Quantitative PCR

• Digital PCR

North America Digital PCR and qPCR Market Analysis By Application

• Tumors

• Blood Testing
• Pathogen Detection
• Research & Forensics

North America Digital PCR and qPCR Market Analysis By End User

• Hospitals

• Research & Forensic Centers
• Pharmaceutical & Bio-Technological Firms
• Academic Institutions

North America Digital PCR and qPCR Market Analysis By Country

• United States

• Canada

• Rest of North America

Regionally, the U.S. digital PCR and the qPCR market is estimated to account for the most significant share in the North American market during the forecast period owing to the factors such as increasing adoption of PCR methods in forensics labs and diagnostic centers, growing applications of technologically advanced PCR and qPCR products. On the other hand, the market in Canada is overgrowing at a high pace. It is likely to dominate the North American market over the prediction period owing to the actors such as increasing investments from government and private organizations or research and development activities of genomics.

KEY MARKET PLAYERS

A few of the promising companies operating in the North America Digital PCR and qPCR market are Thermo Fisher Scientific Inc., F Hoffman-La Roche Ltd., Bio-Rad Laboratories, Qiagen N.V., Taraka Bio Inc., Affymetrix Inc., Agilent Technologies Inc., Fluidigm Corporation, Danaher Corporation, and Becton & Dickson Company.